120 related articles for article (PubMed ID: 36725401)
41. Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer.
Park JW; Chang HJ; Kim BC; Yeo HY; Kim DY
Colorectal Dis; 2013 Sep; 15(9):e503-11. PubMed ID: 23711333
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and safety analysis of bevacizumab combined with capecitabine in the maintenance treatment of RAS-mutant metastatic colorectal cancer.
Huang W; Zhang H; Tian Y; Cha Y; Xiong H; Yuan X
J Clin Pharm Ther; 2022 Apr; 47(4):531-538. PubMed ID: 35218209
[TBL] [Abstract][Full Text] [Related]
43. Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer.
Sørbye H; Dahl O
Acta Oncol; 2004; 43(5):495-8. PubMed ID: 15360055
[TBL] [Abstract][Full Text] [Related]
44. Carcinoembryonic antigen reduction after medical treatment in patients with metastatic colorectal cancer: a systematic review and meta-analysis.
Colloca GA; Venturino A; Guarneri D
Int J Colorectal Dis; 2019 Apr; 34(4):657-666. PubMed ID: 30671635
[TBL] [Abstract][Full Text] [Related]
45. Carcinoembryonic antigen (CEA) and alkaline phosphatase in progressive colorectal cancer with special reference to patient survival.
Aabo K; Pedersen H; Kjaer M
Eur J Cancer Clin Oncol; 1986 Feb; 22(2):211-7. PubMed ID: 3699082
[TBL] [Abstract][Full Text] [Related]
46. Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma.
Ito K; Hibi K; Ando H; Hidemura K; Yamazaki T; Akiyama S; Nakao A
Jpn J Clin Oncol; 2002 Feb; 32(2):54-8. PubMed ID: 11948229
[TBL] [Abstract][Full Text] [Related]
47. Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer.
Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Fan FS; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
Int J Colorectal Dis; 2001 Apr; 16(2):96-101. PubMed ID: 11355325
[TBL] [Abstract][Full Text] [Related]
48. Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma.
Shani A; O'Connell MJ; Moertel CG; Schutt AJ; Silvers A; Go VL
Ann Intern Med; 1978 May; 88(5):627-30. PubMed ID: 646245
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance.
Peng S; Huang P; Yu H; Wen Y; Luo Y; Wang X; Zhou J; Qin S; Li T; Chen Y; Liu G; Huang M
Medicine (Baltimore); 2018 Mar; 97(10):e0044. PubMed ID: 29517661
[TBL] [Abstract][Full Text] [Related]
50. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer.
Goldstein MJ; Mitchell EP
Cancer Invest; 2005; 23(4):338-51. PubMed ID: 16100946
[TBL] [Abstract][Full Text] [Related]
51. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer.
Ramphal W; Boeding JRE; van Iwaarden M; Schreinemakers JMJ; Rutten HJT; Crolla RMPH; Gobardhan PD
Int J Biol Markers; 2019 Mar; 34(1):60-68. PubMed ID: 30852955
[TBL] [Abstract][Full Text] [Related]
52. Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.
Xu X; Yu Y; Shen M; Liu M; Wu S; Liang L; Huang F; Zhang C; Guo W; Liu T
BMC Cancer; 2020 Oct; 20(1):1006. PubMed ID: 33066758
[TBL] [Abstract][Full Text] [Related]
53. Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.
Connell LC; Boucher TM; Chou JF; Capanu M; Maldonado S; Kemeny NE
J Surg Oncol; 2017 Mar; 115(4):480-487. PubMed ID: 28008623
[TBL] [Abstract][Full Text] [Related]
54. Carcinoembryonic antigen (CEA) monitoring of radiation therapy for colorectal cancer.
Sugarbaker PH; Bloomer WD; Corbett ED; Chaffey JT
AJR Am J Roentgenol; 1976 Oct; 127(4):641-4. PubMed ID: 970537
[TBL] [Abstract][Full Text] [Related]
55. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.
Moertel CG; O'Fallon JR; Go VL; O'Connell MJ; Thynne GS
Cancer; 1986 Aug; 58(3):603-10. PubMed ID: 3731019
[TBL] [Abstract][Full Text] [Related]
56. Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma.
Arnaud JP; Koehl C; Adloff M
Dis Colon Rectum; 1980 Apr; 23(3):141-4. PubMed ID: 7379666
[TBL] [Abstract][Full Text] [Related]
57. Biomarkers for the early detection of relapses in metastatic colorectal cancers.
Chereches G; Barbos O; Buiga R; Balacescu O; Iancu D; Todor N; Balacescu L; Miron N; Bejinariu N; Ciuleanu TE
J BUON; 2017; 22(3):658-666. PubMed ID: 28730771
[TBL] [Abstract][Full Text] [Related]
58. The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials.
Wolmark N; Fisher B; Wieand HS; Henry RS; Lerner H; Legault-Poisson S; Deckers PJ; Dimitrov N; Gordon PH; Jochimsen P
Ann Surg; 1984 Apr; 199(4):375-82. PubMed ID: 6370155
[TBL] [Abstract][Full Text] [Related]
59. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
Bakalakos EA; Burak WE; Young DC; Martin EW
Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
[TBL] [Abstract][Full Text] [Related]
60. Basal proteinuria as a prognostic factor in patients with metastatic colorectal cancer treated with bevacizumab.
Uysal M; Bozcuk H; Sezgin Göksu S; Murat Tatli A; Arslan D; Gündüz S; Senol Coskun H; Ozdogan M; Savas B
Biomed Pharmacother; 2014 May; 68(4):409-12. PubMed ID: 24721326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
